-
Founded in:
2001-08-01 -
Country:
China -
Address:
Anhui Changfeng Shuangfeng Economic Development Zone -
Tax NO.:
913401217300302871 -
Registered Funds:
1 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naproxen |
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.
More
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins. |
22204-53-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naproxen |
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.
More
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins. |
22204-53-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Prazosin hydrochloride |
1. A selective postsynaptic α1 receptor blocker that relaxes vascular smooth muscle, dilates peripheral blood vessels, reduces peripheral vascular resistance, and lowers blood pressure; 2. It dilates arteries and veins, reduces cardiac preload and afterload, improves cardiac function, and has a rapid onset of action in the treatment of heart failure, reaching a peak in 1 hour and lasting for 6 hours; 3. It has little effect on renal blood flow and glomerular filtration rate, and can relieve dysuria in patients with prostatic hyperplasia by blocking α1 receptors in the bladder neck, prostate capsule and gland, and urethra; 4. Animal experiments have shown that most drugs are bound to α1 acid glycoprotein, and only 5% of the drugs exist in free form.
More
1. A selective postsynaptic α1 receptor blocker that relaxes vascular smooth muscle, dilates peripheral blood vessels, reduces peripheral vascular resistance, and lowers blood pressure; 2. It dilates arteries and veins, reduces cardiac preload and afterload, improves cardiac function, and has a rapid onset of action in the treatment of heart failure, reaching a peak in 1 hour and lasting for 6 hours; 3. It has little effect on renal blood flow and glomerular filtration rate, and can relieve dysuria in patients with prostatic hyperplasia by blocking α1 receptors in the bladder neck, prostate capsule and gland, and urethra; 4. Animal experiments have shown that most drugs are bound to α1 acid glycoprotein, and only 5% of the drugs exist in free form. |
19237-84-4 | 20 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Allopurinol |
Inhibit uric acid synthesis by inhibiting xanthine oxidase to prevent hypoxanthine and xanthine from being metabolized into uric acid, thereby reducing uric acid production, lowering the uric acid content in the blood and urine, preventing the deposition of uric acid crystals and helping to redissolve uric acid crystals in the tissues of gout patients; it can also inhibit new purine synthesis in the body by inhibiting the action of hypoxanthine-guanine phosphate nuclease.
More
Inhibit uric acid synthesis by inhibiting xanthine oxidase to prevent hypoxanthine and xanthine from being metabolized into uric acid, thereby reducing uric acid production, lowering the uric acid content in the blood and urine, preventing the deposition of uric acid crystals and helping to redissolve uric acid crystals in the tissues of gout patients; it can also inhibit new purine synthesis in the body by inhibiting the action of hypoxanthine-guanine phosphate nuclease. |
315-30-0 | 64 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Alginic Sodium Diester |
This product is an acidic polysaccharide drug with strong dispersing and emulsifying properties, improving the viscoelasticity of blood rheology, and an anticoagulant effect equivalent to 1/3 to 1/2 of heparin. It prevents platelet adhesion to collagen and inhibits platelet aggregation. It has prostaglandin (PGI2)-like effects such as anti-thrombosis, lowering blood viscosity, micro-arteriovenous spasm, and red blood cell and platelet depolymerization. It can significantly lower blood lipids, cholesterol, triglycerides, low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), increase high-density lipoprotein (HDL), inhibit the occurrence and development of atherosclerotic lesions, dilate peripheral blood vessels, improve microcirculation, and inhibit the formation of thrombi in arteries and veins. It also has multiple functions such as lowering blood sugar and blood pressure.
More
This product is an acidic polysaccharide drug with strong dispersing and emulsifying properties, improving the viscoelasticity of blood rheology, and an anticoagulant effect equivalent to 1/3 to 1/2 of heparin. It prevents platelet adhesion to collagen and inhibits platelet aggregation. It has prostaglandin (PGI2)-like effects such as anti-thrombosis, lowering blood viscosity, micro-arteriovenous spasm, and red blood cell and platelet depolymerization. It can significantly lower blood lipids, cholesterol, triglycerides, low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), increase high-density lipoprotein (HDL), inhibit the occurrence and development of atherosclerotic lesions, dilate peripheral blood vessels, improve microcirculation, and inhibit the formation of thrombi in arteries and veins. It also has multiple functions such as lowering blood sugar and blood pressure. |
9005-40-7 | 11 |